Logo image of DAVA

ENDAVA PLC- SPON ADR (DAVA) Stock Fundamental Analysis

NYSE:DAVA - New York Stock Exchange, Inc. - US29260V1052 - ADR - Currency: USD

14.95  +0.42 (+2.89%)

After market: 14.9 -0.05 (-0.33%)

Fundamental Rating

5

Taking everything into account, DAVA scores 5 out of 10 in our fundamental rating. DAVA was compared to 82 industry peers in the IT Services industry. DAVA has an average financial health and profitability rating. DAVA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year DAVA was profitable.
DAVA had a positive operating cash flow in the past year.
Each year in the past 5 years DAVA has been profitable.
DAVA had a positive operating cash flow in each of the past 5 years.
DAVA Yearly Net Income VS EBIT VS OCF VS FCFDAVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

With a Return On Assets value of 0.56%, DAVA perfoms like the industry average, outperforming 45.12% of the companies in the same industry.
DAVA has a Return On Equity of 0.84%. This is comparable to the rest of the industry: DAVA outperforms 48.78% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.50%, DAVA is in line with its industry, outperforming 43.90% of the companies in the same industry.
DAVA had an Average Return On Invested Capital over the past 3 years of 9.56%. This is significantly below the industry average of 21.61%.
The 3 year average ROIC (9.56%) for DAVA is well above the current ROIC(0.50%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.56%
ROE 0.84%
ROIC 0.5%
ROA(3y)9.09%
ROA(5y)8.43%
ROE(3y)12.79%
ROE(5y)12.33%
ROIC(3y)9.56%
ROIC(5y)9.48%
DAVA Yearly ROA, ROE, ROICDAVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

The Profit Margin of DAVA (0.72%) is comparable to the rest of the industry.
DAVA's Profit Margin has declined in the last couple of years.
DAVA has a Operating Margin (0.76%) which is in line with its industry peers.
DAVA's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 22.92%, DAVA is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of DAVA has declined.
Industry RankSector Rank
OM 0.76%
PM (TTM) 0.72%
GM 22.92%
OM growth 3Y-42.43%
OM growth 5Y-25.01%
PM growth 3Y-38.1%
PM growth 5Y-22.63%
GM growth 3Y-12.29%
GM growth 5Y-7.83%
DAVA Yearly Profit, Operating, Gross MarginsDAVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

DAVA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for DAVA has been increased compared to 1 year ago.
The number of shares outstanding for DAVA has been increased compared to 5 years ago.
Compared to 1 year ago, DAVA has a worse debt to assets ratio.
DAVA Yearly Shares OutstandingDAVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
DAVA Yearly Total Debt VS Total AssetsDAVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

DAVA has an Altman-Z score of 3.02. This indicates that DAVA is financially healthy and has little risk of bankruptcy at the moment.
DAVA has a Altman-Z score of 3.02. This is comparable to the rest of the industry: DAVA outperforms 48.78% of its industry peers.
DAVA has a debt to FCF ratio of 5.17. This is a neutral value as DAVA would need 5.17 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.17, DAVA is in line with its industry, outperforming 56.10% of the companies in the same industry.
DAVA has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
DAVA has a Debt to Equity ratio (0.25) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 5.17
Altman-Z 3.02
ROIC/WACC0.06
WACC8.19%
DAVA Yearly LT Debt VS Equity VS FCFDAVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

DAVA has a Current Ratio of 1.88. This is a normal value and indicates that DAVA is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.88, DAVA is doing good in the industry, outperforming 60.98% of the companies in the same industry.
A Quick Ratio of 1.88 indicates that DAVA should not have too much problems paying its short term obligations.
DAVA's Quick ratio of 1.88 is fine compared to the rest of the industry. DAVA outperforms 63.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
DAVA Yearly Current Assets VS Current LiabilitesDAVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for DAVA have decreased strongly by -24.75% in the last year.
DAVA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.26% yearly.
Looking at the last year, DAVA shows a decrease in Revenue. The Revenue has decreased by -6.79% in the last year.
DAVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.81% yearly.
EPS 1Y (TTM)-24.75%
EPS 3Y-4.56%
EPS 5Y8.26%
EPS Q2Q%54.55%
Revenue 1Y (TTM)-6.79%
Revenue growth 3Y18.4%
Revenue growth 5Y20.81%
Sales Q2Q%11.74%

3.2 Future

The Earnings Per Share is expected to grow by 15.83% on average over the next years. This is quite good.
Based on estimates for the next years, DAVA will show a small growth in Revenue. The Revenue will grow by 5.77% on average per year.
EPS Next Y0.87%
EPS Next 2Y2.79%
EPS Next 3Y7.73%
EPS Next 5Y15.83%
Revenue Next Year4.07%
Revenue Next 2Y1.95%
Revenue Next 3Y3.15%
Revenue Next 5Y5.77%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DAVA Yearly Revenue VS EstimatesDAVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
DAVA Yearly EPS VS EstimatesDAVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.90, the valuation of DAVA can be described as reasonable.
Based on the Price/Earnings ratio, DAVA is valued cheaper than 93.90% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.04. DAVA is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 9.24, which indicates a very decent valuation of DAVA.
DAVA's Price/Forward Earnings ratio is rather cheap when compared to the industry. DAVA is cheaper than 93.90% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 37.64. DAVA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.9
Fwd PE 9.24
DAVA Price Earnings VS Forward Price EarningsDAVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DAVA is on the same level as its industry peers.
71.95% of the companies in the same industry are more expensive than DAVA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.3
EV/EBITDA 16.89
DAVA Per share dataDAVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DAVA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)11.42
PEG (5Y)1.2
EPS Next 2Y2.79%
EPS Next 3Y7.73%

0

5. Dividend

5.1 Amount

No dividends for DAVA!.
Industry RankSector Rank
Dividend Yield N/A

ENDAVA PLC- SPON ADR

NYSE:DAVA (7/25/2025, 8:04:00 PM)

After market: 14.9 -0.05 (-0.33%)

14.95

+0.42 (+2.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)N/A N/A
Inst Owners89.32%
Inst Owner Change0.25%
Ins Owners0.61%
Ins Owner ChangeN/A
Market Cap888.84M
Analysts76.47
Price Target23.67 (58.33%)
Short Float %4.83%
Short Ratio2.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.34%
Min EPS beat(2)16.16%
Max EPS beat(2)18.52%
EPS beat(4)3
Avg EPS beat(4)11.92%
Min EPS beat(4)-4.63%
Max EPS beat(4)18.52%
EPS beat(8)7
Avg EPS beat(8)11.51%
EPS beat(12)10
Avg EPS beat(12)8.98%
EPS beat(16)14
Avg EPS beat(16)9.89%
Revenue beat(2)0
Avg Revenue beat(2)-2.02%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)-1.71%
Revenue beat(4)0
Avg Revenue beat(4)-2.21%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)-1.71%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)1
Avg Revenue beat(12)-1.22%
Revenue beat(16)2
Avg Revenue beat(16)-0.85%
PT rev (1m)0.54%
PT rev (3m)-37.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.03%
Valuation
Industry RankSector Rank
PE 9.9
Fwd PE 9.24
P/S 0.86
P/FCF 19.3
P/OCF 16.9
P/B 1
P/tB 22.64
EV/EBITDA 16.89
EPS(TTM)1.51
EY10.1%
EPS(NY)1.62
Fwd EY10.82%
FCF(TTM)0.77
FCFY5.18%
OCF(TTM)0.88
OCFY5.92%
SpS17.31
BVpS14.92
TBVpS0.66
PEG (NY)11.42
PEG (5Y)1.2
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 0.84%
ROCE 0.69%
ROIC 0.5%
ROICexc 0.54%
ROICexgc 2.7%
OM 0.76%
PM (TTM) 0.72%
GM 22.92%
FCFM 4.48%
ROA(3y)9.09%
ROA(5y)8.43%
ROE(3y)12.79%
ROE(5y)12.33%
ROIC(3y)9.56%
ROIC(5y)9.48%
ROICexc(3y)13.4%
ROICexc(5y)13.08%
ROICexgc(3y)36.98%
ROICexgc(5y)34.67%
ROCE(3y)13.11%
ROCE(5y)12.99%
ROICexcg growth 3Y-39.57%
ROICexcg growth 5Y-33.59%
ROICexc growth 3Y-51.03%
ROICexc growth 5Y-40.4%
OM growth 3Y-42.43%
OM growth 5Y-25.01%
PM growth 3Y-38.1%
PM growth 5Y-22.63%
GM growth 3Y-12.29%
GM growth 5Y-7.83%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 5.17
Debt/EBITDA 3.62
Cap/Depr 12.44%
Cap/Sales 0.64%
Interest Coverage 0.82
Cash Conversion 87.04%
Profit Quality 617.5%
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z 3.02
F-Score3
WACC8.19%
ROIC/WACC0.06
Cap/Depr(3y)34.71%
Cap/Depr(5y)33.76%
Cap/Sales(3y)1.53%
Cap/Sales(5y)1.59%
Profit Quality(3y)177.22%
Profit Quality(5y)174.57%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.75%
EPS 3Y-4.56%
EPS 5Y8.26%
EPS Q2Q%54.55%
EPS Next Y0.87%
EPS Next 2Y2.79%
EPS Next 3Y7.73%
EPS Next 5Y15.83%
Revenue 1Y (TTM)-6.79%
Revenue growth 3Y18.4%
Revenue growth 5Y20.81%
Sales Q2Q%11.74%
Revenue Next Year4.07%
Revenue Next 2Y1.95%
Revenue Next 3Y3.15%
Revenue Next 5Y5.77%
EBIT growth 1Y-91.84%
EBIT growth 3Y-31.84%
EBIT growth 5Y-9.4%
EBIT Next Year50.57%
EBIT Next 3Y28.07%
EBIT Next 5Y19.46%
FCF growth 1Y-71.12%
FCF growth 3Y-15.93%
FCF growth 5Y11.88%
OCF growth 1Y-70.57%
OCF growth 3Y-14.72%
OCF growth 5Y9.03%